Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UGT1A4 polymorphisms and lamotrigine pharmacokinetics
ChiCTR-TRC-11001686Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lamotrigine (3 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoint: Blood drug concentration of lamotrigine. Started Aug 2010; status: completed.
02
Drugs
lamotrigine
Beyond the preview
Go deeper on ChiCTR-TRC-11001686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001686.